-Injection in murine tumors shows the compound is well tolerated -Studies support ongoing clinical trial of PH-762 as a neoadjuvant therapy for treatment of cSCC, melanoma, or Merkel cell carcinoma ...
Phio Pharmaceuticals Corp. (Nasdaq: PHIO) is a clinical stage biotechnology company whose proprietary INTASYLâ„¢ siRNA gene silencing technology is designed to make immune cells more effective in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback